IRIS
RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.797
NA - Nord America 2.424
AS - Asia 584
SA - Sud America 16
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 5.838
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.407
IE - Irlanda 1.190
IT - Italia 592
GB - Regno Unito 343
CN - Cina 208
SG - Singapore 203
DE - Germania 178
UA - Ucraina 160
GR - Grecia 82
FR - Francia 66
KR - Corea 63
FI - Finlandia 47
TR - Turchia 40
SE - Svezia 38
RO - Romania 24
IN - India 19
BE - Belgio 16
CZ - Repubblica Ceca 14
IR - Iran 14
NL - Olanda 13
CA - Canada 12
RU - Federazione Russa 11
ID - Indonesia 10
EG - Egitto 8
PK - Pakistan 8
TW - Taiwan 6
CO - Colombia 5
ES - Italia 5
BR - Brasile 4
CH - Svizzera 4
JP - Giappone 4
PE - Perù 4
EU - Europa 3
HU - Ungheria 3
MK - Macedonia 3
MX - Messico 3
CL - Cile 2
HK - Hong Kong 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
PT - Portogallo 2
RS - Serbia 2
UG - Uganda 2
VN - Vietnam 2
AN - Antille olandesi 1
AR - Argentina 1
AU - Australia 1
BW - Botswana 1
HR - Croazia 1
LI - Liechtenstein 1
LT - Lituania 1
MA - Marocco 1
PA - Panama 1
PL - Polonia 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 5.838
Salva come PNG Salva come JPEG
Città #
Dublin 1.176
Chandler 425
Jacksonville 291
Princeton 162
Roxbury 157
New York 154
Singapore 115
Bremen 105
Cambridge 91
Caserta 85
Medford 74
Naples 72
Seoul 62
Ann Arbor 58
Des Moines 51
Wilmington 50
Beijing 48
Boardman 33
Napoli 29
Ashburn 28
Redwood City 26
Nanjing 25
Woodbridge 25
Milan 20
Washington 20
Mountain View 18
Brussels 16
Atlanta 15
Jinan 15
Shenyang 14
Helsinki 13
Houston 13
San Francisco 12
Giugliano In Campania 11
London 11
Munich 11
Norwalk 11
Monserrato 10
San Mateo 10
Amsterdam 9
Lappeenranta 9
Timisoara 9
Aversa 8
Marano Di Napoli 8
Taizhou 8
Brno 7
Chicago 7
Florence 7
Haikou 7
Liveri 7
Stuttgart 7
Zanjan 7
Changsha 6
Hebei 6
Lanzhou 6
Los Angeles 6
Paris 6
Perugia 6
Sacramento 6
Taipei 6
Tianjin 6
Zhengzhou 6
Duncan 5
Fairfield 5
Nanchang 5
Philadelphia 5
Samsun 5
Auburn Hills 4
Carinaro 4
Chennai 4
Hangzhou 4
Istanbul 4
Kunming 4
Ningbo 4
Nonantola 4
Orange 4
Pomezia 4
Rho 4
Seattle 4
Zurich 4
Andover 3
Bogotá 3
Bologna 3
Boydton 3
Buffalo 3
Changchun 3
Dearborn 3
Eboli 3
Elora 3
Groningen 3
Hanover 3
Hefei 3
Lima 3
Modugno 3
Mohali 3
Moscow 3
Portici 3
Rome 3
Shanghai 3
Altamura 2
Totale 3.858
Salva come PNG Salva come JPEG
Nome #
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 101
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 91
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 90
Bartter syndrome 83
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 78
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 77
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 75
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 70
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: Identification of eleven novel pathogenic sequence variants 67
Chronic HCV infection and neurological and psychiatric disorders: an overview. 64
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 62
Sonoporation by microbubbles as gene therapy approach against liver cancer 62
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 61
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 58
Pulsed laser ablation of magnetic nanoparticles as a novel antibacterial strategy against gram positive bacteria 58
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 56
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 55
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 55
Spirometry in elderly laryngectomized patients: A feasibility study 52
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 51
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 51
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 51
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 50
HCV-related steatosis and risk of atherosclerosis 50
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 50
Chronic HCV infection is a risk factor of ischemic stroke 50
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study 49
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 48
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 48
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 48
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 47
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 47
Chronic Hepatitis C Virus Infection and Depression. 46
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 46
Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment. Predictive Factors and Role of Epigenetics 46
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 45
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 45
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 45
A genic and epigenetic combination therapy for liver cancer 45
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 45
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 45
Seasonal variations of hyponatremia in the emergency department: Age-related changes 44
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 44
HCC and molecular targeting therapies: Back to the future 44
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 44
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 43
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 43
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 42
Renal handling of uric acid 42
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 42
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 42
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 41
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 41
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 41
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 40
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 40
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 40
Prediction of SARS-CoV-2-Related Lung Inflammation Spreading by V:ERITAS (Vanvitelli Early Recognition of Inflamed Thoracic Areas Spreading) 40
Patho-physiology of renal dysfunction in Bardet-Biedl Syndrome 39
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 39
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 39
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 39
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 39
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact 38
Cardiovascular benefits from gliflozins: Effects on endothelial function 38
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 38
[Next Generation Sequencing and ADPKD] 37
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 37
Steatosis is a determinant of fibrosis progression in chronic hepatitis C and is correlated both with body composition and viral factors 36
High HDL Cholesterol: a risk factor for Diabetic Retinopathy? Findings from NO BLIND study 36
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 36
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 35
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis 35
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 35
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 35
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 35
Atypical presentation of a rare parasitic infection with fasciola hepatica: A multidisciplinary case report 34
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 34
Diagnostic performance of LI-RADS in adult patients with rare hepatic tumors 34
Nonalcoholic fatty liver disease: Evolving paradigms 33
Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients 33
Non-alcoholic fatty liver disease beyond the liver is an emerging multifaceted systemic disease 33
Hepatocellular carcinoma in patients with cryptogenic and metabolic cirrhosis: Incidence, characteristics, risk factors and survival 33
The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology 32
Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress 32
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 32
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage 31
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis. 31
TISSUE RESONANCE INTERACTION METHOD: A CHALLENGE FOR THE EARLY AND NON-INVASIVE DIAGNOSIS OF SOLID CANCERS 31
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 31
Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow 31
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 31
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis. 30
SARS-CoV-2 vaccine development: Where are we? 30
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience 29
The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C. 29
Impact of hepatitis C virus clearance b direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study 29
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 29
Antioxidant diet and genotyping as tools for the prevention of liver disease 29
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 29
Totale 4.492
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.242
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020362 0 0 10 18 69 18 97 29 24 26 49 22
2020/2021646 29 28 40 32 111 35 149 43 16 39 94 30
2021/20221.037 27 4 20 30 314 20 16 23 72 75 97 339
2022/20232.095 191 64 58 92 262 126 6 108 1.074 21 40 53
2023/20241.213 87 33 57 73 330 183 51 38 24 43 106 188
2024/2025103 30 73 0 0 0 0 0 0 0 0 0 0
Totale 6.259